Switch to:
More From Other Websites
Fight over hot new cholesterol drugs may be won in milligrams May 26 2015
The Most Loved Biotechs of Big Hedge Funds May 23 2015
What You May Have Missed in Biotech: Eye Drug Fails, Ear Drug Flops, and Herpes Drug Succeeds May 23 2015
3 Top IBD 50 Stocks Hit New All-Time Highs May 21 2015
Regeneron-Sanofi's Sarilumab Meets Endpoints in Phase III - Analyst Blog May 21 2015
Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in... May 21 2015
Sanofi and Regeneron Announce Positive Topline Results from Phase 3 Studies with Sarilumab in... May 21 2015
Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in... May 21 2015
Cramer: This is the absolute worst thing in this market May 20 2015
Cramer: Bail out now on this group May 20 2015
Jim Cramer -- Regeneron Will Go Higher; Sarepta Is Rallying May 20 2015
Move Over Chip Stocks: Here Are 5 Top Biotechs May 20 2015
10 S&P 500 Companies to Have the Most Revenue Growth in 2015 May 20 2015
Cramer's Mad Dash: Regeneron goes higher May 20 2015
Cramer: This went from $5 to $500 and isn't done May 19 2015
Healthcare Winners and Losers: May 19, 2015 May 19 2015
Regeneron/Sanofi Announce Positive Data on Dupilumab - Analyst Blog May 19 2015
Regeneron Shares Seen Reaching $525 May 19 2015
Sanofi and Regeneron Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the... May 18 2015
Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the... May 18 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK